1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,064 | 0,081 | 15.11. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | hVIVO develops three new human challenge models for viral testing | 3 | Investing.com | ||
| Di | hVIVO meldet erfolgreiche Entwicklung von drei neuen humanen Challenge-Modellen | 1 | Investing.com Deutsch | ||
| Di | hVIVO PLC - Positive data from novel human challenge models | - | RNS | ||
| 03.11. | hVIVO PLC - Presentation at Jefferies Healthcare Conference | - | RNS | ||
| 23.09. | HVIVO Slides To Loss In H1 | - | RTTNews | ||
| 23.09. | hVIVO PLC - Interim results | - | RNS | ||
| 04.09. | hVIVO PLC - Notice of Results | 4 | RNS | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 01.09. | hVIVO appoints Avacta Chair Shaun Chilton to lead board | 1 | Alliance News | ||
| 01.09. | hVIVO PLC - Appointment of Non-Executive Chair | - | RNS | ||
| 29.07. | hVIVO PLC - Proposed appointment of Chair | - | RNS | ||
| 22.07. | hVIVO PLC - H1 Trading update | 1 | RNS | ||
| 18.07. | hVIVO PLC - Directorate Change | - | RNS | ||
| 09.07. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
| 30.06. | hVivo reports positive results from its largest lab contract to date | 1 | Sharecast | ||
| 30.06. | hVIVO reports positive results from Cidara's Phase 2b influenza study | 3 | Investing.com | ||
| 30.06. | hVIVO PLC - Positive results from client Phase 2b field study | - | RNS | ||
| 05.06. | hVIVO PLC - Result of AGM | - | RNS | ||
| 02.06. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 30.05. | Hvivo client cancels 'significant' HCT trial contract | 1 | Sharecast | ||
| 30.05. | hVIVO PLC - Trading update | - | RNS |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,510 | -2,54 % | Plus Therapeutics Inc.: Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights | US market introduction of the CNSide® CSF diagnostics platform, with first national coverage agreement with UnitedHealthcare Presented positive RESPECT-LM Ph1 clinical trial results HOUSTON, Oct.... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| JD HEALTH INTERNATIONAL | 7,500 | -0,66 % | M Stanley: JD HEALTH 3Q Results Beat Strongly | ||
| LIFEWARD | 0,600 | +15,25 % | Lifeward Ltd. Reports Third Quarter 2025 Financial Results | Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27%... ► Artikel lesen | |
| EKSO BIONICS | 4,800 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Third Quarter 2025 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 3,600 | -1,10 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 0,785 | -0,38 % | Rockwell Medical: Umsatzrückgang im dritten Quartal lässt Aktie einbrechen | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 24,600 | -0,65 % | Viridian Therapeutics auf der Stifel-Konferenz: Strategische Positionierung im TED-Markt | ||
| SINTX TECHNOLOGIES | 3,160 | +2,93 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
| AETHLON MEDICAL | 5,090 | +7,38 % | Aethlon Medical, Inc.: Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update | Clinical and research progress continues alongside substantial cost reductions.
Conference Call Today at 4:30 p.m. ET
SAN DIEGO, Nov. 12, 2025 /PRNewswire/... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
| SAVARIA | 13,800 | -0,72 % | Savaria Corporation: Continued Margin Enhancements Push Savaria to Reach New Profitability Heights in Q3 2025 | LAVAL, Québec, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Savaria Corporation ("Savaria") (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for the third... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report |
HVIVO PLC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,063 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.